Affluent Medical Sas Stock
Price
Target price
€1.81
€1.81
2.560%
0.045
2.560%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Financial data and news for Affluent Medical Sas
sharewise wants to provide you with the best news and tools for Affluent Medical Sas, so we directly link to the best financial data sources.
Financials
News
EQS-News: Affluent Medical to attend German Fall Conference in Frankfurt in September 2024
EQS-News: Affluent Medical to attend German Fall Conference in Frankfurt in September 2024
Affluent Medical announces the availability of a prospectus for the admission to trading of 6,190,831 shares issued as part of a capital increase without preferential subscription rights.
Affluent Medical announces the availability of a prospectus for the admission to trading of 6,190,831 shares issued as part of a capital increase without preferential subscription rights.
EQS-News: Affluent Medical announces the availability of a prospectus for the admission to trading of 6,190,831 shares issued as part of a capital increase without preferential subscription rights in favour of
EQS-News: Affluent Medical announces the availability of a prospectus for the admission to trading of 6,190,831 shares issued as part of a capital increase without preferential subscription rights in favour of
EQS-News: Affluent Medical signs agreements for mitral valve technologies with EUR 15M upfront payment
EQS-News: Affluent Medical signs agreements for mitral valve technologies with EUR 15M upfront payment
Affluent Medical signs agreements for mitral valve technologies with EUR 15M upfront payment.
Affluent Medical signs agreements for mitral valve technologies with EUR 15M upfront payment.
EQS-News: Affluent Medical achieves the clinical objective of the Dry pilot study in the first two patients with the Artus artificial urinary sphincter
EQS-News: Affluent Medical achieves the clinical objective of the Dry pilot study in the first two patients with the Artus artificial urinary sphincter
Affluent Medical achieves the clinical objective of the Dry pilot study in the first two patients with the Artus artificial urinary sphincter.
Affluent Medical achieves the clinical objective of the Dry pilot study in the first two patients with the Artus artificial urinary sphincter.
Affluent Medical : 2023 financial results and update on clinical activities under development.
Affluent Medical : 2023 financial results and update on clinical activities under development.
Affluent Medical announces coverage initiation of its stock by Gilbert Dupont – Société Générale Group.
Affluent Medical announces coverage initiation of its stock by Gilbert Dupont – Société Générale Group.
Affluent Medical announces coverage initiation of its stock by TP ICAP Midcap.
Affluent Medical announces coverage initiation of its stock by TP ICAP Midcap.
Affluent Medical announces successful first-in-human implantation of its artificial sphincter Artus for the treatment of stress urinary incontinence.
Affluent Medical announces successful first-in-human implantation of its artificial sphincter Artus for the treatment of stress urinary incontinence.
Affluent Medical : Excellent valve performance at 1 year follow up and rising recognition of Epygon biomimetic mitral valve.
Affluent Medical : Excellent valve performance at 1 year follow up and rising recognition of Epygon biomimetic mitral valve.